Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

Background  Crohn's disease is associated with small bowel cancer whilst risk of colorectal cancer is less clear.

[1]  Noam Harpaz,et al.  Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. , 2004, Gastroenterology.

[2]  F. Casellas,et al.  Influence of inflammatory bowel disease on different dimensions of quality of life , 2001, European journal of gastroenterology & hepatology.

[3]  B. Crohn,et al.  The sigmoidoscopic picture of chronic ulcerative colitis (non-specific) , 1925 .

[4]  A. Ristimäki.  Cyclooxygenase 2: from inflammation to carcinogenesis. , 2004, Novartis Foundation symposium.

[5]  S. Sommers,et al.  Cicatrizing enteritis as a pathologic entity; analysis of 120 cases. , 1948, The American journal of pathology.

[6]  P. Munkholm,et al.  Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. , 2002, Gastroenterology.

[7]  W. Bloquiaux.  [Crohn's disease and cancer]. , 1968, Tijdschrift voor gastro-enterologie.

[8]  A. Ahlbom,et al.  Crohn's disease and cancer: a population-based cohort study. , 1994, Gastroenterology.

[9]  J. Inadomi.  Cost-Effectiveness of Colorectal Cancer Surveillance in Ulcerative Colitis , 2003, Scandinavian journal of gastroenterology. Supplement.

[10]  J. Olsen,et al.  Crohn's disease and cancer risk (Denmark) , 2000, Cancer Causes & Control.

[11]  D. Palli,et al.  A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). , 1996, Scandinavian journal of gastroenterology.

[12]  D. Sackett.  Bias in analytic research. , 1979, Journal of chronic diseases.

[13]  G. Williams,et al.  Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. , 1995, European journal of gastroenterology & hepatology.

[14]  P. Schoenfeld,et al.  The epidemiology and natural history of Crohn’s disease in population‐based patient cohorts from North America: a systematic review , 2002, Alimentary pharmacology & therapeutics.

[15]  S. Travis,et al.  Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.

[16]  J. Macartney,et al.  Malignancy in Crohn's disease. , 1980, Gut.

[17]  R. Ahlquist,et al.  Increasing incidence of Crohn's disease. , 1983, American journal of surgery.

[18]  H. Johnson,et al.  A comparison of 'traditional' and multimedia information systems development practices , 2003, Inf. Softw. Technol..

[19]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[20]  J. Barton,et al.  Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. , 1989, Gut.

[21]  P. Munkholm,et al.  Intestinal and extra‐intestinal cancer in Crohn's disease: follow‐up of a population‐based cohort in Copenhagen County, Denmark , 2004, Alimentary pharmacology & therapeutics.

[22]  Z. Fireman,et al.  Intestinal cancer in patients with Crohn's disease. A population study in central Israel. , 1989, Scandinavian journal of gastroenterology.

[23]  E. Giovannucci.  An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[25]  H. Schreiber,et al.  Inflammation as a tumor promoter in cancer induction. , 2004, Seminars in cancer biology.

[26]  S. Kersting,et al.  Intestinal cancer in patients with Crohn’s disease , 2007, International Journal of Colorectal Disease.

[27]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[28]  D. Sachar,et al.  A comparison of cancer risk in crohn's disease and ulcerative colitis , 1981, Cancer.

[29]  David R. Jones,et al.  An illustrated guide to the methods of meta-analysis. , 2001, Journal of evaluation in clinical practice.

[30]  P. J. Kelly,et al.  Inflammatory bowel disease: epidemiology and management in an English general practice population , 2000, Alimentary pharmacology & therapeutics.

[31]  L. Melton,et al.  Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. , 1988, Gut.

[32]  P Hungin,et al.  Working together across international boundaries: improving the primary-secondary care network. , 2001, European journal of gastroenterology & hepatology.

[33]  Y. Lacasse,et al.  From the authors , 2005, European Respiratory Journal.

[34]  H. Adami,et al.  Increased risk of large-bowel cancer in Crohn's disease with colonic involvement , 1990, The Lancet.

[35]  R. Hubbard,et al.  Mortality in inflammatory bowel disease: a population-based cohort study. , 2003, Gastroenterology.

[36]  A. Lilienfeld,et al.  Trends in incidence rates of ulcerative colitis and Crohn's disease , 1984, Digestive Diseases and Sciences.

[37]  W. Padberg,et al.  [Malignant tumors of the small intestine]. , 1994, Zentralblatt fur Chirurgie.

[38]  L. Elveback,et al.  Incidence of Crohn's disease in Olmsted County, Minnesota, 1935-1975. , 1980, American journal of epidemiology.

[39]  P. Prior.  Malignancy in crohn's disease. , 1972, British journal of preventive & social medicine.